Home
Issues
2018
April 2018, Vol 7, No 1
2017
December 2017, Vol 6, No 5
October 2017, Vol 6, No 4
August 2017, Vol 6, No 3
June 2017, Vol 6, No 2
April 2017, Vol 6, No 1
2016
December 2016, Vol 5, No 6
October 2016, Vol 5, No 5
August 2016, Vol 5, No 4
June 2016, Vol 5, No 3
April 2016, Vol 5, No 2
February 2016, Vol 5, No 1
Issues Archive
Supplements
Categories
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In The News
Online First
Videos
About
About VBCR
About Engage HC
Contact Us
Editorial/Publishing Policies
Editorial Board
Advertising Contacts
Advertising Policy
Author Guidelines
Friday, 29 March 2024
Walter Alexander
Authored Items
Imaging Confirms 4-Year Reductions in Axial Spondyloarthritis Inflammation with Certolizumab Pegol
Walter Alexander
VBCR - August 2017, Vol 6, No 3
in
EULAR News
Reduced Vertebral Fracture Risk with Romosozumab in the Phase 3 FRAME Study
Walter Alexander
VBCR - August 2017, Vol 6, No 3
in
EULAR News
Challenges in Central Neuropathic Pain Syndromes
Walter Alexander
VBCN - November 2016 Volume 3, No 3
in
Pain Management
Noninvasive Brain Stimulation as a Therapeutic Modality
Walter Alexander
VBCN - November 2016 Volume 3, No 3
in
Pain Management
Secukinumab Provides Sustained Benefits to 104 Weeks in Ankylosing Spondylitis
Walter Alexander
VBCR - October 2016, Vol 5, No 5
in
Ankylosing Spondylitis
Four-Year Trial Outcomes Show Sustained Certolizumab Pegol Efficacy in Patients with Axial Spondyloarthritis
Walter Alexander
VBCR - October 2016, Vol 5, No 5
in
Ankylosing Spondylitis
Bimekizumab, an IL-17A and IL-17F Inhibitor, Produces High Responses in Skin and Joints in Patients with Psoriatic Arthritis
Walter Alexander
VBCR - August 2016, Vol 5, No 4
in
Psoriatic Arthritis
Combination Immunotherapy the New Standard for Patients with Metastatic Melanoma
Walter Alexander
VBCC - June 2016, Vol 7, No 5
in
Melanoma
Debating the Role of Intralesional Therapy in Melanoma
Walter Alexander
VBCC - June 2016, Vol 7, No 5
in
Melanoma
Promising Locoregional Therapies for Hepatocellular Carcinoma and Metastatic CRC
Walter Alexander
VBCC - December 2015, Vol 6, No 11
in
Emerging Therapies
Ramucirumab Confers Survival Benefit in Some Patients with Hepatocellular Carcinoma
Walter Alexander
VBCC - November 2015, Vol 6, No 10
in
GI Cancers
Systemic Therapy plus Radiofrequency: Ablation Survival Benefit in Colorectal Liver Metastases
Walter Alexander
VBCC - November 2015, Vol 6, No 10
in
GI Cancers
Aprepitant Improves Emesis Control in Patients with Colorectal Cancer
Walter Alexander
VBCC - November 2015, Vol 6, No 10
in
GI Cancers
Adding Radiation to First-Line FOLFOX Reduces Liver Metastases Progression in Patients with Metastatic Colorectal Cancer
Walter Alexander
VBCC - June 2015, Vol 6, No 5
in
ASCO 2015 Highlights
Favorable Long-Term Survival with Nivolumab Monotherapy in Advanced Melanoma
Walter Alexander
VBCC - December 2014, Vol 5, No 10
in
Melanoma Management
BRAF-Mutated Melanoma: Improved Overall Survival with BRAF/MEK Inhibition “Closes the Book” on Benefit
Walter Alexander
VBCC - December 2014, Vol 5, No 10
in
Melanoma Management
Last modified: December 23, 2014
Home
Issues
2018
April 2018, Vol 7, No 1
2017
December 2017, Vol 6, No 5
October 2017, Vol 6, No 4
August 2017, Vol 6, No 3
June 2017, Vol 6, No 2
April 2017, Vol 6, No 1
2016
December 2016, Vol 5, No 6
October 2016, Vol 5, No 5
August 2016, Vol 5, No 4
June 2016, Vol 5, No 3
April 2016, Vol 5, No 2
February 2016, Vol 5, No 1
Issues Archive
Supplements
Categories
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In The News
Online First
Videos
About
About VBCR
About Engage HC
Contact Us
Editorial/Publishing Policies
Editorial Board
Advertising Contacts
Advertising Policy
Author Guidelines